Get the Stockscreener App
2.35
0.43%
0.01
After Hours:
2.34
-0.01
-0.43%
Augmedix Inc stock is traded at $2.35, with a volume of 35,956.
It is up +0.43% in the last 24 hours and up +1.29% over the past month.
Augmedix Inc is engaged in ambulatory/clinical/hospital segments of the U.S. patient care services market with products that address medical note documentation needs. The company's products cater to large and small healthcare organizations but can also be adopted by individual practitioners. The company products extract data from natural clinician-patient conversations and convert it in real time to medical notes, which are seamlessly transferred to the electronic health record (EHR). The company's revenues consist of service fees charged to its customers to subscribe to the company's remote medical documentation and clinical support products.
See More
Previous Close:
$2.34
Open:
$2.34
24h Volume:
35,956
Relative Volume:
0.05
Market Cap:
$115.73M
Revenue:
$44.86M
Net Income/Loss:
$-19.17M
P/E Ratio:
-4.2002
EPS:
-0.5595
Net Cash Flow:
$-18.55M
1W Performance:
+0.86%
1M Performance:
+1.29%
6M Performance:
-42.54%
1Y Performance:
-54.37%
1-Day Range:
$2.34
$2.35
1-Week Range:
$2.33
$2.35
52-Week Range:
$0.73
$6.25
Augmedix Inc Stock (AUGX) Company Profile
Name
Augmedix Inc
Sector
Industry
Phone
561-989-2208
Address
111 SUTTER STREET, SUITE 1300, SAN FRANCISCO
Augmedix Inc Stock (AUGX) Latest News
Augmedix, Inc. (NASDAQ:AUGX) Short Interest Down 18.9% in September - MarketBeat
Augmedix shareholders approve merger with Commure - Investing.com
Augmedix shareholders approve merger with Commure By Investing.com - Investing.com South Africa
Augmedix shareholders approve merger with Commure By Investing.com - Investing.com UK
Augmedix shareholders approve merger with Commure By Investing.com - Investing.com Canada
Augmedix (OTCMKTS:AUGX) Stock Price Up 0.4% - Defense World
Augmedix (OTCMKTS:AUGX) Shares Up 0.4% - MarketBeat
Augmedix, Inc. (NASDAQ:AUGX) Short Interest Update - Defense World
Augmedix, Inc. (NASDAQ:AUGX) Sees Significant Decline in Short Interest - MarketBeat
Augmedix discloses additional merger details amid litigation By Investing.com - Investing.com Australia
Augmedix discloses additional merger details amid litigation - Investing.com India
Augmedix discloses additional merger details amid litigation - Investing.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, CNOB, AUGX on Behalf of Shareholders - GlobeNewswire Inc.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, CNOB, AUGX on Behalf of Shareholders - GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WISA, EVBN, AUGX on Behalf of Shareholders - The Malaysian Reserve
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WISA, EVBN, AUGX on Behalf of Shareholders - Stockhouse Publishing
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
10 Best AI Medical Scribes (September 2024) - Unite.AI
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FYBR, FLIC, GATO, AUGX on Behalf of Shareholders - GlobeNewswire Inc.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates - GlobeNewswire
STOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Merger and Looming Vote on September 27, 2024, of Augmedix, Inc.AUGX - PR Newswire
Augmedix Inc [AUGX] stock for 2,103 USD was sold by Chatterjee Saurav - Knox Daily
Recent Insider Activity Could Benefit Augmedix Inc (AUGX) - Knox Daily
Augmedix Inc: Rising -62.88% from 52-Week Low, Can the Stock Stay Afloat? - The InvestChronicle
Best AR and VR Healthcare Stocks (September 2024) - Securities.io
Augmedix (OTCMKTS:AUGX) Trading Down 0.4% - MarketBeat
Short Interest in Augmedix, Inc. (NASDAQ:AUGX) Rises By 98.6% - MarketBeat
Augmedix (OTCMKTS:AUGX) Stock Price Down 0.4% - Defense World
Augmedix extends agreement with healthcare partners - Investing.com
Augmedix extends agreement with healthcare partners - Investing.com India
Augmedix Inc (AUGX) Becoming More Attractive for Investors - Knox Daily
Augmedix (NASDAQ:AUGX) Stock Quotes, Forecast and News Summary - Benzinga
Augmedix, Inc. (NASDAQ:AUGX) Shares Acquired by Vanguard Group Inc. - Defense World
Augmedix Inc (AUGX)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
Augmedix (OTCMKTS:AUGX) Releases Earnings Results, Misses Estimates By $0.04 EPS - Defense World
Artificial Intelligence (AI) in Healthcare Research Report 2024: Market to Reach $153.61 Billion by 2029, Growing at a Staggering CAGR of 48.49% - GlobeNewswire Inc.
Augmedix, Inc. (NASDAQ:AUGX) Short Interest Down 54.0% in July - MarketBeat
Short Interest in Augmedix, Inc. (NASDAQ:AUGX) Declines By 54.0% - Defense World
AUGX Stock Earnings: Augmedix Misses EPS, Misses Revenue for Q2 2024 - InvestorPlace
Augmedix, Inc. (AUGX) Reports Q2 Loss, Lags Revenue Estimates - MSN
Augmedix, Inc. (AUGX) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Canada Finance
Augmedix Delivers 27% Revenue Growth for Second Quarter of 2024 - wallstreet:online
Augmedix Delivers 27% Revenue Growth for Second Quarter of 2024 - StockTitan
Augmedix reports Q2 EPS (16c), consensus (13c) - TipRanks
Augmedix (AUGX) to Release Earnings on Monday - Defense World
Augmedix to Join Forces with Commure - Healthcare IT Today
Financial Comparison: Broadridge Financial Solutions (NYSE:BR) versus Augmedix (NASDAQ:AUGX) - Defense World
Augmedix (AUGX) Scheduled to Post Earnings on Monday - MarketBeat
Examining the Potential Price Growth of Augmedix Inc (AUGX) - Knox Daily
Manny Krakaris, CEO of Augmedix, on the VatorNews podcast - VatorNews
Boston Partners Grows Stake in Augmedix, Inc. (NASDAQ:AUGX) - Defense World
Augmedix Inc Stock (AUGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.31%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):